National Technical Advisory On Immunisation Ntagi
- All
- News
- Videos
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Gap Between 2nd Covid Jab, Booster Reduced On Immunisation Group Advice: Centre
Based on the recommendations made by the National Technical Advisory Group on Immunisation (NTAGI), the interval between the second and the precaution dose of Covid vaccines was revised from nine months to six months for all beneficiaries.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Expert Panel Considering Evidence On Justification Of Booster Covid Vaccine Dose: Centre
National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunisation (NTAGI) are considering scientific evidences related to justification for booster doses against Covid.
-
Additional Dose For Those At Risk? Covid Panel To Decide Today
The National Technical Advisory Group on Immunisation will meet tomorrow to discuss the administration of additional doses of the Covid vaccine to immunocompromised individuals, officials said.
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Gap Between 2nd Covid Jab, Booster Reduced On Immunisation Group Advice: Centre
Based on the recommendations made by the National Technical Advisory Group on Immunisation (NTAGI), the interval between the second and the precaution dose of Covid vaccines was revised from nine months to six months for all beneficiaries.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Expert Panel Considering Evidence On Justification Of Booster Covid Vaccine Dose: Centre
National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunisation (NTAGI) are considering scientific evidences related to justification for booster doses against Covid.
-
Additional Dose For Those At Risk? Covid Panel To Decide Today
The National Technical Advisory Group on Immunisation will meet tomorrow to discuss the administration of additional doses of the Covid vaccine to immunocompromised individuals, officials said.
